Access EIS investments for March 2021.
As the new tax year begins, SyndicateRoom's added six new startups to the Access EIS portfolio, investing alongside super angels in each case (for more on our super angels, and our co-investment model, see our dedicated page. Find out more about our fund, Access EIS, or read about our new portfolio companies below.
BKwai’s solutions use data science and AI to leverage insights from manual
measurements, sensor data and satellite data to radically radically improve
infrastructure asset management throughout the lifecycle of an asset – from
planning to construction, to long term asset management.
Our angel partner in the round has a weighted IRR of 66% and has invested in digi.
me, fatsoma and smartframe.
Total Round: approx. £400,000
Stage: Post-revenue
Founded by a team of timing, AI, software development and media experts, Hoptroff
is an industry leader in synchronised time. Their clock-sharing system is energy
efficient and reduces the carbon emissions associated with the manufacturing and
maintenance of additional timing equipment.
Our angel partner in the round has a weighted IRR of 49% and has invested in
proSapient, Enertechnos, and Moody, among others.
Total Round: approx. £1,500,000
Stage: Post-revenue
Simply Do Ideas is a cloud-based software platform that aims to empower individuals
and organisations to capture, test and develop entrepreneurial ideas and business
solutions through a dynamic, iterative process incorporating imagery and video.
Our angel partner in the round has a weighted IRR of 41% and has invested in
NeedleSmart, Float, and Trakcel, to name a few.
Total Round: approx. £500,000
Stage: Post-revenue
Technology that reimagines and simplifies the property matchmaking experience by
doing the heavy lifting to uncover the properties that are best suited to each tenant’s
complete personal needs.
Our angel partner in the round has a weighted IRR of 126% and has invested in
Adzuna, Tandem, and VouchedFor, among others.
Total Round: approx. £750,000
Stage: Post-revenue
Establishing an early stage pipeline of inhibitors of drug targets in protein
degradation and immunometabolism. The approach focuses on modelling the
quantum transition state of the catalytic site of enzymes to overcome the key
limitations of existing discovery technologies.
Our angel partner in the round has a weighted IRR of 66% and has invested in
Geospock, Healx, and Gelmetix, among others.
Total Round: approx. £700,000
Stage: Pre-revenue
Action.ai is focused on the creation of intelligent conversational interfaces. The
complexities of language are managed using Language as a Service (Laas) so that
users are easily, no matter how they express themselves.
Our angel partner in the round has a weighted IRR of 41% and has invested in
Cytora, Ebury, and Funding Circle, among others.
Total Round: approx. £750,000
Stage: Post-revenue
You can see our full portfolio on our startups page. For further updates on our startups and investments, follow us on Twitter here.